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Background: The influence of the fractionalization of moderate- to vigorous- intensity physical activity (MVPA)
throughout the week on the health of children is unknown. We compared cardiometabolic risk factors in physically
active children who accumulated their weekly MVPA in different patterns.
Methods: We studied 745 participants aged 6–19 years. MVPA was measured using accelerometers over 7 days.
Three groups were created: Insufficiently Active, <60 minutes/day of MVPA on average; Infrequently Active, ≥60
minutes/day of MVPA on average but exceeding the 60 minute target <5 days; and Frequently Active, ≥60 minutes/
day MVPA on average and exceeding the 60 minute target ≥5 days. Percentile scores for 8 cardiometabolic risk
factors were determined.
Results: The least favorable cardiometabolic risk factor profile was observed in the Insufficiently Active group. The
Frequently Active group had more favorable (5–6 percentile unit difference) diastolic blood pressure, HDL-cholesterol,
insulin resistance, and metabolic syndrome scores than the Infrequently Active group, although only the difference for
insulin resistance was statistically significant (P < 0.05). These differences remained after controlling for the weekly
volume of MVPA.
Conclusion: The fractionalization of MVPA throughout the week was associated with insulin resistance.Background
Physical activity guidelines of the World Health Or-
ganization [1], United States [2,3], and Canada [4] all
recommend that school-aged children and youth accu-
mulate at least 60 minutes of moderate- to vigorous-
intensity physical activity (MVPA) every day for health
benefits. A recent systematic review on the health bene-
fits of physical activity in school-aged children and youth
noted that, while there is evidence to conclude that an
average of 60 minutes/day of MVPA is associated with
meaningful health benefits, there is no evidence to support
the daily frequency recommendation [5]. In other words,
the fractionalization of MVPA throughout the week may
not be important, and it is possible that an average of
60 minutes/day of MVPA is just as beneficial as 60 minutes
every day. Consistent with this observation, physical* Correspondence: ian.janssen@queensu.ca
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reproduction in any medium, provided the oractivity guidelines for adults have changed from the
recommendation to accumulate 30 minutes of MVPA on
most or all days of the week [6,7] to the recommendation
to accumulate 150 minutes over the week [1,3,4]. This
change was made because existing evidence does not per-
mit researchers to say, for example, whether the benefits
of 30 minutes of MVPA 5 days/week are different from
the benefits of 50 minutes of MVPA on 3 days/week [8,9].
It is unclear as to whether the fractionalization of a
young person’s volume of MVPA throughout the week
impacts their health. Only a few studies have compared
the benefits of several week days of MVPA to those of a
few days, when the dose of MVPA is controlled for, and
these studies are limited to adults. One of these studies
consisted of a prospective cohort of older men followed
for mortality over 9 years [10]. Within that study physic-
ally active men (≥1000 kcal/week) were classified as
infrequently (active 1–2 days/week) or regularly (active
3–7 days/week) active based upon the number of days
they exercised each week. Compared to inactive men,l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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men and by 36% in regularly active men. The twofold
greater risk reduction in regularly active than infre-
quently active men suggests that the recommendation to
fractionalize weekly MVPA over several days may be
relevant. Additional studies, particularly in young people,
are needed.
Our objective was to compare cardiometabolic risk
factors in physically active children and youth (i.e., ≥60
minutes/day on average) who accumulate their weekly
MVPA in different patterns (i.e., ≥60 minutes on 1–
4 days/week vs. 5–7 days/week). We hypothesized that,
after controlling for the total dose of MVPA, children and
youth who were active more frequently would have more
favorable cardiometabolic risk factors than children
and youth who are active less frequently. This hy-
pothesis was based on the knowledge that, in addition
to chronic effects, MVPA has acute effects on several
cardiometabolic risk factors that can last for as long
as three or four days [11].
Methods
Data source
Data are from the Canadian Health Measures Survey
(CHMS), a nationally representative sample of Canadians
aged 6 to 79 years living in private households [12-15].
Residents of Indian Reserves or Crown lands, institutions,
certain remote regions, and full-time members of the
Canadian Forces are excluded. Approximately 96% of
Canadians are represented. The CHMS involved two
components: 1) an in-home interview (completed by
proxy for those aged <12 years) to gather information
on socio-demographic characteristics, health behaviors,
and environmental factors, and 2) a mobile examination
clinic visit for direct physical measures and biospecimen
collection. To be included in this study, participants had
to be 6–19 years old, have acceptable accelerometry
measures of MVPA, and have measures available for all
of the cardiometabolic risk factors.
Ethics approval was obtained from Health Canada’s
Research Ethics Board [15]. Informed written consent was
obtained from respondents aged 14 years or older. For a
child, a parent/guardian provided written consent, in
addition to written assent from the child. Data were col-
lected at 15 sites from March 2007 through February 2009.
Of the households selected to participate in the
CHMS, the response rate was 69.6%. Within each house-
hold, one (if there were no children aged 6–11 years) or
two (if there was ≥ one child aged 6–11 years) members
were randomly chosen to participate. Half of the CHMS
participants made up the fasted subsample (these partic-
ipants completed their clinic visit in the morning) that
was examined in this paper. Of the selected 6–19 year
olds, 86.8% completed the household questionnaire,87.5% of those participated in the mobile clinic visit, and
85.4% of those were fasted for a total of 933. The overall
response rate for the fasted 6–19 year olds is therefore
45.2%. An additional 188 were excluded because of miss-
ing or incomplete data, leaving a final sample size of 745.
Measurement of physical activity
After the clinic visit, participants were asked to wear an
Actical accelerometer (Phillips – Respironics, Oregon,
USA) during their waking hours over their right hip on
an elasticized belt for 7 consecutive days. The monitors
started collecting data at midnight following the clinic
visit. The Actical measures time-stamped accelerations
in all directions and provides an indication of physical
activity intensity. The digitized values were summed
over 1 minute intervals, resulting in 10,080 count per
minute (cpm) values over the 7 day measurement period.
The Actical has been validated to measure physical activity
in children and youth [16,17].
Cleaning and reduction of accelerometer data
Accelerometer data quality were assessed to determine
whether files should be included in analyses [18]. Pub-
lished guidelines were followed to identify and remove
days with incomplete (invalid) accelerometer wear time
[18,19]. A valid day was defined as ≥10 hours of wear time,
which was determined by subtracting nonwear time from
24 hours. Nonwear time was defined as a period of ≥60
consecutive minutes of zero counts, with allowance for 1
to 2 minutes of counts between 0 and 100.
The next data cleaning step involved removing partici-
pants with an insufficient number of days of valid wear
time. Only participants with ≥4 valid days were included
[18]. A 4–5 day accelerometer monitoring period for
MVPA has a test-retest reliability of 0.7 to 0.8 among
children and youth [20]. Of those child and youth
CHMS participants who wore the accelerometer, 84.8%
had at least 4 valid days (8.2% with 4 days, 12.7% with
5 days, 24.0% with 6 days, 39.8% with 7 days) [21].
Derivation of MVPA variables
Time spent in MVPA was determined for each day with
valid wear time by summing minutes with values ≥
1500 cpm [22]. Average daily minutes of MVPA was cal-
culated for each participant. The number of days over
the 7 day measurement period in which the participants
accumulated ≥60 minutes of MVPA was also determined.
Physical activity recommendations are that school-aged
children and youth accumulate ≥60 minutes of MVPA
daily. Participants in this study were divided into the fol-
lowing 3 groups based on whether they achieved the
60 minute/day target on average over the 7 day measure-
ment period, and if so, the number of days that this target
was achieved: 1) Insufficiently Active = <60 minutes/day of
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(N = 455); 2) Infrequently Active = ≥60 minutes/day of
MVPA on average over the 7 day measurement period,
and active for ≥60 minutes on 1 to 4 days over the 7 days
(N = 106); and 3) Frequently Active = ≥60 minutes/day
MVPA on average over the 7 day measurement period,
and active for ≥60 minutes on 5 to 7 days over the 7 days
(N = 184). The Infrequently Active and Frequently Active
groups were differentiated using the 5 day cut-point
because this cut-point resulted in the most comparably
sized groups.
To maximize the sample size, participants with less
than 7 valid days of wear time were classified into the 3
MVPA groups based on an equivalent percentage of
active days for the number of days they had valid wear
time. For participants with 7 out of 7 days of valid wear
time, 4 out of 7 active days equates to having 57% of all
valid days as active days, for participants with 6 days of
valid wear time this is roughly equivalent to 3 active
days (50%), for participants with 5 days of valid wear
time this is roughly equivalent to 3 active days (60%),
and for participants with 4 days of valid wear time, this
is roughly equivalent to 2 active days (50%).
Measurement of cardiometabolic risk factors
Cardiometabolic risk factor values vary by sex and
change with growth and maturation [23-25]. Therefore,
percentile scores by sex and age were computed for each
cardiometabolic risk factor, and these percentile scores
were used in all regression analyses. Thus, participants
with percentile scores of 2%, 16%, 50%, 84%, and 98%
would reflect individuals with risk factor values for their
sex and age that were 2 SD below the mean, 1 SD below
the mean, at the mean, 1 SD above the mean, and 2SD
above the mean, respectively.
Obesity
Height was measured to the nearest 0.1 cm using a
ProScale M150 digital stadiometer (Accurate Technology
Inc., Fletcher, USA) and weight was measured to the
nearest 0.1 kg with a Mettler Toledo VLC scale (Mettler
Toledo Canada, Mississauga, Canada). The body mass
index (BMI) was calculated as weight divided by height
squared (kg/m2). Waist circumference was measured
with an anthropometric tape at the end of a normal ex-
piration to the nearest 0.1 cm at the mid-point between
the last rib and iliac crest [26]. Overweight and obesity
were determined using the International Obesity Task
Force BMI thresholds [23].
Blood pressure
Blood pressure was measured with the BpTRU™ BP-
300 (BpTRU Medical Devices Ltd., Coquitlam, British
Columbia) [27]. The device automatically inflates anddeflates the arm cuff and uses an oscillometric tech-
nique to calculate systolic and diastolic blood pressure.
It has passed international validation protocols [12,28].
Once appropriate seat height, arm positioning, and cuff
size were determined, a five minute quiet rest was
followed by a minimum of six measurements taken one
minute apart. Systolic and diastolic blood pressure values
were calculated by averaging the last 5 of 6 measures.
Blood measures
Fasting blood samples were taken and analyzed at the
Health Canada Laboratory (Bureau of Nutritional Sci-
ences, Nutrition Research Division). The lipid/lipoprotein
measures considered here were high density lipoprotein
(HDL)-cholesterol and triglycerides. We did not examine
low density lipoprotein-cholesterol because it is poorly
correlated with MVPA in children and youth [29]. HDL-
cholesterol and triglycerides were measured using a
non-HDL precipitation method and enzymatic method,
respectively, and were performed on the Vitros 5,1FS
(Ortho Clinical Diagnostics). Insulin resistance was esti-
mated according to the homoeostasis model assessment
(HOMA) as the product of fasting glucose (mmol/L)
and insulin (μU/mL) divided by 22.5 [30]. Insulin was
measured using a solid-phase, two-site chemilumines-
cent immunometric assay (Immulite 2000 by DPC).
Glucose was measured on the Vitros 5,1FS (Ortho Clinical
Diagnostics).
Metabolic syndrome
Percentile scores of the seven individual risk factors were
averaged for each participant to create a clustered meta-
bolic syndrome risk score [31]. HDL-cholesterol scores
were multiplied by −1 prior to incorporating them into
the metabolic syndrome score.
Covariates
Covariates included visible minority status (white or
other) and total household income adjusted for the
number of people in the household (lowest quartile vs.
other). Age and sex were not included as covariates
because the cardiometabolic risk factor percentile scores
were age- and sex-specific.
Statistical analyses
Statistical analyses were performed using SAS v9.1 and
SUDAAN v10. Some of the cardiometabolic risk factor
values were positively skewed (triglycerides and HOMA)
and were log transformed prior to analyses. All analyses
were weighted to obtain estimates that are representative
of the Canadian population [32]. To account for survey
design effects, 95% confidence intervals (CI) were esti-
mated using the bootstrap technique [33,34], with the
degrees of freedom specified as 11 [32].
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regression tests were used to assess the univariate rela-
tions between MVPA and the cardiometabolic risk factors.
Differences between cardiometabolic risk factors across
the three physical activity groups were assessed using gen-
eral linear models. The 95% CI of the parameter estimates
(b) from these regression models were used to identify
group differences. Visible minority status and household
income were included as covariates in the models. Two
models were run for each cardiometabolic risk factor. The
first model included the 3 physical activity groups and the
covariates. The second model included the 3 physical
activity groups, the covariates, and the volume of MVPA
(average min/day). There was a 21 minute/day difference
in the average daily MVPA in the Infrequently Active and
Frequently Active groups, and the second model con-
trolled for the volume of MVPA to estimate the indepen-
dent effects of the weekly frequency of being active
for ≥60 minutes.
Statistical results were interpreted as recommended by
the British Medical Journal Group [35]. These recommen-
dations indicate that: 1) CI for effect sizes are preferable
to p-values, 2) inferences drawn by comparing p-values
are dubious, and 3) interpretation of a lack of significance
as evidence of no effect is usually incorrect.
Based on a sample size of 106 or more per group, a p
value of 0.05, and assuming a standard deviation for the
cardiometabolic risk factor percentile scores of 15 within
each group, the study had an 80% power to detect a 5




A description of the 745 participants is in Table 1. The
average age was 12.4 years, 48.7% were male, and 25.6%Table 1 Descriptive characteristics: 6–19 year old 2007/09 Ca
Variable Total sample Insuffi
Age, years 12.4 (12.1, 12.8) 13.1
MVPA
Average min/day (mean) 55.1 (49.5, 60.7) 36.1
≥60 min/day on average (%) 39.9 (31.8, 48.6)
BMI, kg/m2 20.3 (19.7, 20.8) 21.0
Waist circumference, cm 68.7 (67.2, 70.2) 70.7
Systolic blood pressure, mmHg 96.3 (95.1, 97.5) 97.1
Diastolic blood pressure, mmHg 62.2 (61.1, 63.4) 62.7
HDL-cholesterol, mmol/L 1.3 (1.3, 1.4) 1.3
Triglycerides, mmol/L 0.8 (0.8, 0.9) 0.9
Insulin resistance, HOMA score 2.1 (1.96, 2.2) 2.2
Data for continuous variables are shown as mean (95% confidence interval).
Data for categorical variables are shown as prevalence (95% confidence interval).were overweight or obese. The average daily MVPA was
55.1 minutes. A total of 455 participants (61.1%) accumu-
lated <60 minutes/day of MVPA on average (Insufficiently
Active group), 106 (14.2%) accumulated ≥60 minutes/day
of MVPA on average but were only active for ≥60 minutes
on 1–4 days of the week (Infrequently Active group), and
184 (24.7%) accumulated ≥60 minutes/day of MVPA on
average and were active for ≥60 minutes on 5–7 days of
the week (Frequently Active group). The average daily
minutes of MVPA in these 3 groups were 36.1 (95% CI:
34.1, 38.2), 70.0 (95% CI: 67.7, 72.3), and 90.9 (95% CI:
85.0, 96.8), respectively.
Relation between MVPA and cardiometabolic risk factors
Correlation coefficients (r values) between the MVPA
and cardiometabolic risk factors were as follows: 0.16 for
BMI, 0.16 for waist circumference, 0.11 for systolic
blood pressure, 0.13 for diastolic blood pressure, -0.12
for HDL-cholesterol, 0.06 for triglycerides, 0.22 for insu-
lin resistance, and 0.23 for the metabolic syndrome.
Thus, 0.4% (triglycerides) to 5.3% (metabolic syndrome)
of the variance in the cardiometabolic risk factors was
explained by MVPA.
Differences in cardiometabolic risk factor percentile
scores across the 3 physical activity groups are shown in
Table 2. The data in this table represent the parameter
estimates (b) from the regression models, with the
Frequently Active group acting as the referent. Thus,
parameter estimates greater than 0 indicate higher
percentile scores than in the Frequently Active group;
parameter estimates less than 0 indicate lower percentile
scores.
After controlling for the covariates in Model 1, a less
favorable overall cardiometabolic risk factor profile was
noted in the Insufficiently Active group than in the
Frequently Active group (Table 2). With the exception ofnadian health measures survey participants
ciently active Infrequently active Frequently active
(12.6, 13.6) 12.0 (10.8, 13.2) 11.1 (10.3, 12.0)
(34.1, 38.2) 70.0 (67.7, 72.3) 90.9 (85.0, 96.8)
0 100 100
(20.2, 21.8) 19.4 (18.3, 20.6) 18.9 (17.9, 19.8)
(68.3, 73.0) 66.1 (63.0, 69.2) 66.5 (62.3, 68.6)
(95.5, 98.7) 95.9 (93.7, 98.1) 94.7 (93.5, 95.9)
(61.4, 64.1) 62.9 (60.5, 65.3) 60.8 (59.4, 62.1)
(1.2, 1.4) 1.3 (1.3, 1.4) 1.4 (1.3, 1.4)
(0.8, 1.0) 0.8 (0.7, 0.9) 0.7 (0.6, 0.8)
(2.0, 2.4) 2.2 (1.6, 2.9) 1.6 (1.3, 1.9)
Table 2 Differences in cardiometabolic risk factor percentile scores across the physical activity groups: 6–19 year old
2007/09 Canadian health measures survey participants
Cardiometabolic risk
factor
Insufficiently active <60 min/day
MVPA on average, b (95% CI)
≥60 min/day MVPA on average
Infrequently active ≥60 min on 1–4 days,
b (95% CI)
Frequently active ≥60 min on 5–7 days,
b (95% CI)
BMI
Model 1a 5.69 (−0.66, 12.05) −2.59 (−9.63, 4.46) referent
Model 2b 2.66 (−5.30, 10.62) −3.78 (−12.63, 5.07) referent
Waist circumference
Model 1a 5.34 (−2.69, 13.36) −3.93 (−10.08, 2.21) referent
Model 2b 0.65 (−5.20, 6.50) −5.78 (−12.86, 1.30) referent
Systolic blood pressure
Model 1a 4.19 (0.51, 7.87)c 0.94 (−9.41, 11.29) referent
Model 2b −3.80 (−12.49, 4.88) −2.21 (−12.88, 8.46) referent
Diastolic blood pressure
Model 1a 6.45 (2.42, 10.48)c 6.66 (−5.42, 18.75) referent
Model 2b 2.01 (−5.52, 9.54) 4.91 (−7.16, 16.99) referent
HDL-cholesterol
Model 1a −6.45 (−12.78, -0.13)c −5.58 (−15.87, 4.72) referent
Model 2b −3.46 (−14.29, 7.36) −4.40 (−15.42, 6.62) referent
Triglycerides
Model 1a 1.04 (−1.10, 3.18) 0.90 (−2.09, 3.89) referent
Model 2b −0.13 (−3.52, 3.26) 0.44 (−3.07, 3.94) referent
Insulin resistance
Model 1a 5.79 (−0.54, 12.13) 5.29 (0.15, 11.74)c referent
Model 2b 6.52 (−4.14, 17.17) 6.10 (−0.10, 12.30) referent
Metabolic syndrome
Model 1a 5.95 (0.15, 11.74)c 5.03 (−2.49, 12.55) referent
Model 2b 0.65 (−5.27, 6.54) 3.30 (−4.56, 11.16) referent
Data presented as parameter estimate (b) and the 95% confidence interval for these estimates as obtained from generalized linear models predicting percentile
scores of cardiometabolic risk factors from the physical activity groups. The Frequently Active group acted as the referent (b = 0.00) for all analyses.
a Model 1 controlled for visible minority status and household income.
b Model 2 controlled for variables in Model 1 + volume of MVPA (average minutes per day).
c Significantly different from referent group (P < 0.05).
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higher (lower for HDL-cholesterol) in the Insufficiently
Active group. There was a substantial variability for most
of the parameter estimates, and the differences between
the Insufficiently Active and Frequently Active groups
only reached statistical significance (p < 0.05) for 4 of the
8 risk factors.
After controlling for the covariates in Model 1, there
were noticeable differences (5 to 7 percentile units) in
the average diastolic blood pressure, HDL-cholesterol,
insulin resistance, and metabolic syndrome scores
between the Infrequently Active and Frequently Active
groups. However, the only statistically significant (p < 0.05)
difference was for insulin resistance, wherein a 5.29 (95%
CI: 0.15, 11.74) higher percentile score was observed in the
Infrequently Active group.To explore whether the differences in cardiometabolic
risk factors between the Infrequently Active and Frequently
Active groups were attributable solely to the 21 minutes/
day higher average MVPA levels in the Frequently Active
group, or whether there was an independent effect of the
daily frequency of being active for ≥60 minutes, additional
models were run that controlled for the average minutes/
day of MVPA (see Model 2 in Table 2). An attenuation of
the percentile scores in model 2 vs. model 1 would indi-
cate that the differences between these two groups in
model 1 were attributable to the higher average MVPA
levels in the Frequently Active group. The general pattern
of findings was that the percentile scores in model 2 for
the Infrequently Active group were not closer, or were only
marginally closer (i.e., slightly attenuated), to those of the
Frequently Active group than they were for model 1.
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addition of BMI percentile score as an additional covari-
ate influenced the associations observed in Model 2 of
Table 2. No discernible differences in the results were
observed versus those reported for Model 2 (data not
shown).
Discussion
Our primary objective was to compare cardiometabolic
risk factors in physically active children and youth who
accumulated their weekly MVPA in different patterns. A
key finding was that Infrequently Active children and
youth – children and youth who accumulated 60 minutes
of MVPA on average per day but who met this 60 minute
target <5 days per week – were more insulin resistant
than Frequently Active children and youth. This is an
important observation given the strong, independent
effects that insulin resistance has on the development of
type 2 diabetes [36,37] and coronary heart disease
[38,39]. The differences in insulin resistance between
Infrequently Active and Frequently Active children and
youth appeared to be attributable to differences in the
weekly frequency of meeting the daily target of 60 minutes
of MVPA rather than to differences in the weekly volume
of MVPA. There were also notable differences in diastolic
blood pressure, HDL-cholesterol, and metabolic syndrome
scores between the Infrequently Active and Frequently
Active children and youth, although these differences were
not statistically significant.
To our knowledge, no previous pediatric studies have
investigated the independent health influence of the
weekly fractionalization of MVPA. Previous population-
based studies of children and youth from the United
States and Europe have documented a relationship be-
tween average daily MVPA, as measured by accelerom-
eter, with individual cardiometabolic risk factors [29,40]
and summary cardiometabolic risk factors scores [31,41].
Our findings that physically active Canadian children
and youth tend to have a more favorable overall
cardiometabolic risk factor profiles than their insuffi-
ciently active counterparts is consistent with these prior
observations. These findings also support the new phys-
ical activity guidelines of the World Health Organization
[1], United States [2,3], and Canada [4] which recom-
mend that school-aged children and youth accumulate ≥
60 minutes of MVPA on a daily basis. A unique recom-
mendation within Canada’s guidelines is that “More
physical activity provides greater health benefits” [4]. In
other words, while children and youth should strive to
accumulate 60 minutes daily, those who accumulate >
60 minutes will achieve even greater health benefits.
This was also supported by findings of our study. In
particular, the average insulin resistance percentile score
of Infrequently Active children and youth, who had anaverage daily MVPA of 70 minutes, was 5.29 units
higher than in Frequently Active children and youth,
who had an average daily MVPA of 91 minutes (see
Table 2).
It has been well documented that MVPA has acute
effects on several cardiometabolic risk factors [11]. The
acute effects on lipids and lipoproteins are most pro-
nounced for triglycerides and HDL-cholesterol. These
effects occur 18–24 hours after exercise and persist for
up to 72 hours [11]. Reductions in systolic and diastolic
blood pressure occur immediately after exercise; how-
ever, these changes are short-lived and last for 16 hours
or less [11]. The acute effects on insulin resistance are
also immediate, but can last for 3 or 4 days [11]. Based
on these observations, it was not surprising that the
differences in insulin resistance between the Infrequently
Active and Frequently Active groups remained after
adjusting for differences in the volume of MVPA across
these two groups.
Our findings have potential public health implications.
Namely, they suggest that, as implied in current physical
activity guidelines, engagement in 60 minutes of MVPA
on a daily or near daily basis is beneficial to the
cardiometabolic health of children and youth. In other
words, from a health perspective, it appears to be more
beneficial for a young person to accumulate 7 hours of
weekly MVPA over 7 days than over 4 days. Further-
more, encouraging children and youth to be active on a
daily basis may help them accumulate more activity over
the course of a week. In this study Frequently Active
participants accumulated 146 more minutes of MVPA
over the week than Infrequently Active participants.
This study had several limitations. First, the car-
diometabolic risk factors were assessed in the clinic visit
on the day prior to the 7-day MVPA measurement
period. Therefore, when assigning participants to MVPA
groups, we assumed that the MVPA patterns were con-
sistent in the week prior to and following the clinic visit.
Second, for participants with less than 7 days of valid
accelerometer wear time we made assumptions about
their weekly pattern of physical activity when assigning
them to a physical activity group. It is unclear if this led
to differential or non-differential misclassification of the
exposure variable, and therefore whether the observed
associations were under or overestimated. Third, this
was a cross-sectional study that does not provide
temporal evidence. Fourth, a significant percentage of
the CHMS sample was excluded from the analyses
because of incomplete or missing data. This decreased
the sample size and we may have been underpowered
for some of the analyses, particularly those that com-
pared the Infrequently Active (N = 108) and Frequently
Active (N = 184) groups. Firth, because of sample size
limitations, we could not perform the analyses separately
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the CHMS do not accurately capture physical activities
that are not step-based such as swimming, cycling, and
weight training [42].
Conclusion
Our findings support the notion that the fractionaliza-
tion of MVPA throughout the week is important for
cardiometabolic health, at least for insulin resistance.
These findings set the stage for tightly controlled interven-
tion studies, which could more adequately address the
relevance of the weekly fractionalization of MVPA.
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